SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,570.35 -373.93
( -0.49%)

Global Indices

Nasdaq

52,794.59 -412.31
(-0.77%)

Dow Jones

7,653.60 -53.54
(-0.69%)

Hang Seng

64,415.54 -1,799.80
(-2.72%)

Nikkei 225

10,761.93 -27.35
(-0.25%)

Forex

USD-INR

95.24 -0.24
(-0.25%)

EUR-INR

110.49 -0.08
(-0.07%)

GBP-INR

128.99 -0.20
(-0.15%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Anuh Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

506260

INE489G01022

35.1435185

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ANUHPHR

18.42

814.32

EPS(TTM)

Face Value()

Div & Yield %

4.41

1.85

Back

jost`s engineering company ltd

Gufic BioSciences consolidated net profit declines 35.68% in the December 2025 quarter

Feb 14,2026

Net profit of Gufic BioSciences declined 35.68% to Rs 12.42 crore in the quarter ended December 2025 as against Rs 19.31 crore during the previous quarter ended December 2024. Sales rose 11.37% to Rs 231.41 crore in the quarter ended December 2025 as against Rs 207.79 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	231.41	207.79	11
OPM %	14.25	16.33	-
PBDT	25.41	30.88	-18
PBT	17.72	26.26	-33
NP	12.42	19.31	-36

76,570.35 -373.93 ( -0.49%)

52,794.59 -412.31 (-0.77%)

7,653.60 -53.54 (-0.69%)

64,415.54 -1,799.80 (-2.72%)

10,761.93 -27.35 (-0.25%)

95.24 -0.24 (-0.25%)

110.49 -0.08 (-0.07%)

128.99 -0.20 (-0.15%)

0.60 0.00 (-0.03%)